Your browser doesn't support javascript.
loading
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.
Jacobson, Caron A; Chavez, Julio C; Sehgal, Alison R; William, Basem M; Munoz, Javier; Salles, Gilles; Munshi, Pashna N; Casulo, Carla; Maloney, David G; de Vos, Sven; Reshef, Ran; Leslie, Lori A; Yakoub-Agha, Ibrahim; Oluwole, Olalekan O; Fung, Henry Chi Hang; Rosenblatt, Joseph; Rossi, John M; Goyal, Lovely; Plaks, Vicki; Yang, Yin; Vezan, Remus; Avanzi, Mauro P; Neelapu, Sattva S.
Afiliação
  • Jacobson CA; Department of medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: caron_jacobson@dfci.harvard.edu.
  • Chavez JC; University of South Florida H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Sehgal AR; UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
  • William BM; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Munoz J; Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
  • Salles G; Department of Hematology and Medicine, Centre Hopitalier Lyon-Sud, University of Lyon, Pierre-Bénite, France.
  • Munshi PN; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.
  • Casulo C; University of Rochester Medical Center, James P Wilmot Cancer Center, Rochester, NY, USA.
  • Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • de Vos S; Ronald Reagan University of California Los Angeles Medical Center, Los Angeles, CA, USA.
  • Reshef R; Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY, USA.
  • Leslie LA; John Theurer Cancer Center, Hackensack, NJ, USA.
  • Yakoub-Agha I; Centre Hospitalier Régional Universitaire de Lille, INSERM U1286, Lille, France.
  • Oluwole OO; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Fung HCH; Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Rosenblatt J; University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA.
  • Rossi JM; Kite Pharma, Santa Monica, CA, USA.
  • Goyal L; Kite Pharma, Santa Monica, CA, USA.
  • Plaks V; Kite Pharma, Santa Monica, CA, USA.
  • Yang Y; Kite Pharma, Santa Monica, CA, USA.
  • Vezan R; Kite Pharma, Santa Monica, CA, USA.
  • Avanzi MP; Kite Pharma, Santa Monica, CA, USA.
  • Neelapu SS; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lancet Oncol ; 23(1): 91-103, 2022 01.
Article em En | MEDLINE | ID: mdl-34895487
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Linfoma não Hodgkin Tipo de estudo: Clinical_trials / Guideline Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Linfoma não Hodgkin Tipo de estudo: Clinical_trials / Guideline Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article